BlogNews

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team

King of Prussia, PA  – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.

Catherine brings more than a decade of experience in the life science industry as a creative and insightful marketer. She has extensive knowledge in branding, marketing strategy development, campaign management, content marketing, event management, lead generation, and a deep understanding of the clinical trial industry and eClinical technologies. In her new role as VP, Marketing, Catherine will define CluePoints’ partnership and global marketing strategies and identify key opportunities for market differentiation to help drive new business and retain existing business. She will also be responsible for seeking out opportunities for joint marketing initiatives to lead to revenue-generating growth.

Céline has 16 years of experience in HR acquired through several roles in the sector, resulting in a holistic view of the HR functions and a real taste for talent management, employee experience, and organization transformation. She is passionate about actively shaping an organization to realize its purpose and strategy and growing and activating talent teams around business goals. As VP, People, she will be responsible for the overall people experience and capability building at CluePoints. This newly created position forms part of the company’s mission to attract, engage, develop, and retain the best talent in a competitive and international environment across multiple locations: Belgium, the United States, and the United Kingdom.

James is a proven leader with a demonstrated ability to motivate cross-functional teams, deliver results, and create sustainable change over a career spanning two decades. He also served in the United States Army as an Operations and Intelligence Officer with several assignments in Europe and spent 14 years in various commercial and operations assignments in the electronic security industry. In his new role as VP, Business Operations, he will support the CEO to help define, operationalize, and track the company’s strategic and operational initiatives in rapid business growth.

The three new appointments come at a time of exciting international growth for CluePoints and aim to support the leadership team and organization.

Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, said: “We are delighted to have recruited these talented leaders in their fields to join the CluePoints team as we look to the future.”

“Catherine brings impressive experience in developing and executing marketing strategies aligned with company goals to hit desired revenue targets. Her agile approach to ensure marketing tactics yield high-quality results makes her an excellent fit for our company at a moment of increased growth in recognition of our pioneering work.”

“We are also excited to welcome Céline and her ability to shape organizations to inspire and enable employees to do what they do best with ease and fun. She will offer strategic guidance to our talented HR team in Belgium and the US while providing high-value people solutions in the fields of organization development, talent acquisition, development, and engagement, as well as co-designing global reward processes and best practices.”

“In James, we have someone with a strong background in business process improvement and managing complex projects. He is also a trained coach who is well-versed in helping clients with their professional development and personal fulfillment, which makes him ideal for promoting CluePoints’ core values around respect, care, innovation, and simplicity and ensuring smooth collaboration between different teams.”

Catherine, who achieved an honor of distinction in her BA in Communications and Public Relations, said: “I am looking forward to taking on a challenging role where my strategic initiatives can play a part in accelerating CluePoints’ growth even further. I am excited to build a stronger brand reputation and increase customer retention and satisfaction to contribute to the overall company profitability.”

Céline, a Leadership in People advisor and an employee experience architect, added: “This new role is the perfect opportunity for me to build on an existing work environment that enables people to actively contribute to the organization’s ambition. I am committed to bringing an outside-in and customer-focused perspective and will bring a drive to explore innovative paths and make things work in an efficient but fun way.”

“I am proud to be able to bring my extensive experience in communication, project management, process improvement, and problem-solving to my new position at CluePoints. I look forward to ensuring the company’s internal processes are well suited for its rapid growth and designing and implementing business operations which align with company strategies,” adds James, a certified Project Management Professional.

For further information on CluePoints’ solutions, please visit www.cluepoints.com

 

About CluePoints

CluePoints is the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software. Our products utilize comprehensive statistical algorithms to determine clinical trial data quality, accuracy, and integrity, both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints® is deployed to support central and on-site monitoring, medical review, quality risk management, and drive a holistic risk-based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls, and solution implementation, you now have everything you need to adhere to global regulatory guidance. The result is increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBx.